Trans Genic Group Inc. · TSE:2342

Trans Genic — FY2011 Earnings Presentation

25 slides from Trans Genic's earnings presentation, May 27, 2011

1. Slide 1: http://www.transgenic.co.jp

   http://www.transgenic.co.jp

2. Slide 2: Copyright© TransGenic Inc. All Rights Reserved.

   Copyright© TransGenic Inc. All Rights Reserved. 1

3. Slide 3: Copyright© TransGenic Inc. All Rights Reserved.

   Copyright© TransGenic Inc. All Rights Reserved. 2

4. Slide 4: H22.3 H22.3 TG,PRM

   H22.3 H22.3 H23.3 TG,PRM 603,985 509,100 94,885 382,734 232,487 306,519 74,031 232,487 55,807 77,750 21,942 55,807 94,439 124,830 30,391 94,439 221,251 221,251 373,210 271,666 101,543 187,724 230,775 237,433 6,658 195,011 615,977 370,595 245,381 494,048 143,287 55,947 87,339 143,266 385,201 133,161

5. Slide 5: Copyright© TransGenic Inc. All Rights Reserved.

   22 3 232,487 55,807 94,439 221,251 0 603,985 181,411 151,555 97,182 283,268 275,769 989,187 51,076 95,747 2,743 62,017 275,769 385,201 23 3 306,519 77,750 124,830 0 509,100 251,562 71,458 101,974 217,266 642,261 54,956 6,291 22,855 217,266 133,161 Copyright© TransGenic Inc. All Rights Reserved. 4

6. Slide 6: H22.3 H23.3 Copyright© TransGenic Inc. All Rights Reserved.

   H22.3 H23.3 232,487 306,519 74,031 31.8% 130,409 190,179 59,769 45.8% 102,077 116,340 14,262 14.0% 43.9% 38.0% 13,492 19,750 6,258 46.4% 37,509 41,632 4,123 11.0% 51,076 54,956 3,880 7.6% Copyright© TransGenic Inc. All Rights Reserved. 5

7. Slide 7: H22.3 H23.3 Copyright© TransGenic Inc. All Rights Reserved.

   H22.3 H23.3 55,807 77,750 21,942 39.3% 5,071 24,738 19,666 387.8% 50,735 53,012 2,276 4.5% 90.9% 68.2% 125,295 36,197 89,097 71.1% 21,188 10,523 10,665 50.3% 95,747 6,291 102,039 Copyright© TransGenic Inc. All Rights Reserved. 6

8. Slide 8: H22.3 H23.3 Copyright© TransGenic Inc. All Rights Reserved.

   H22.3 H23.3 94,439 124,830 30,391 32.2% 52,242 56,749 4,506 8.6% 42,196 68,081 25,884 61.3% 44.7% 54.5% 64.8% 4,479 0 4,479 100.0% 40,460 45,225 4,764 11.8% 2,743 22,855 25,599 Copyright© TransGenic Inc. All Rights Reserved. 7

9. Slide 9: Copyright© TransGenic Inc. All Rights Reserved.

   Copyright© TransGenic Inc. All Rights Reserved. 8

10. Slide 10: GANP TG Resource Bank

    GANP / TG Resource Bank® GANP GANP TG IBL Copyright© TransGenic Inc. All Rights Reserved. 9 Immuno-Biological Laboratories

11. Slide 11: Copyright© TransGenic Inc. All Rights Reserved.

    Copyright© TransGenic Inc. All Rights Reserved. 10

12. Slide 12: Copyright© TransGenic Inc. All Rights Reserved.

    640 509 470 435 382 332 324 1,343 928 682 659 605 299 144 Copyright© TransGenic Inc. All Rights Reserved. 11

13. Slide 13: Copyright© TransGenic Inc. All Rights Reserved.

    Copyright© TransGenic Inc. All Rights Reserved. 12

14. Slide 14: Copyright© TransGenic Inc. All Rights Reserved.

    22 3 23 3 Copyright© TransGenic Inc. All Rights Reserved. 13

15. Slide 15: H24.3 forecast

    H23.3 H24.3 509,100 705,778 306,519 407,582 77,750 150,515 124,830 147,681 271,666 336,955 237,433 368,823 370,595 354,774 55,947 50,353 133,161 14,049 144,288 15,612 215,474 10,442 Copyright© TransGenic Inc. All Rights Reserved. 14

16. Slide 16: Copyright© TransGenic Inc. All Rights Reserved.

    705 640 147 66 509 470 150 68 435 124 39 382 75 332 324 94 77 36 25 573 65 67 55 401 33 80 407 284 31 306 208 232 145 15 1,343 928 682 659 605 299 144 Copyright© TransGenic Inc. All Rights Reserved. 15

17. Slide 17: Copyright© TransGenic Inc. All Rights Reserved.

    Copyright© TransGenic Inc. All Rights Reserved. 16

18. Slide 18: Copyright© TransGenic Inc. All Rights Reserved.

    Copyright© TransGenic Inc. All Rights Reserved. 17

19. Slide 19: Copyright© TransGenic Inc. All Rights Reserved.

    ® Copyright© TransGenic Inc. All Rights Reserved. 18

20. Slide 20: Copyright© TransGenic Inc. All Rights Reserved.

    Copyright© TransGenic Inc. All Rights Reserved. 19

21. Slide 21: DiAcSpm CEA CA19-9

    DiAcSpm CEA CA19-9 Stage 0 13/21 (62%) 2/21 (9.5%) 1/21 (4.8%) Stage I 24/40 (60%) 4/40 (10%) 3/40 (7.5%) Stage II 42/60 (70%) 25/60 (42%) 3/60 (5.0%) Stage III 92/113 (81%) 53/113 (47%) 24/113 (21%) Stage IV 14/16 (88%) 10/16 (63%) 5/16 (30%) DiAcSpm CEA CA15-3 Stage I 3/15 (20%) 0/15 (0%) 0/15 (0%

22. Slide 22: Copyright© TransGenic Inc. All Rights Reserved.

    Copyright© TransGenic Inc. All Rights Reserved. 21

23. Slide 23: P P P

    P P P P-OH P-OH Copyright© TransGenic Inc. All Rights Reserved. 22

24. Slide 24: Copyright© TransGenic Inc. All Rights Reserved.

    Copyright© TransGenic Inc. All Rights Reserved. 23

25. Slide 25: http://www.transgenic.co.jp

    http://www.transgenic.co.jp

TransGenic — FY2011 Earnings Presentation on 6ix